353 related articles for article (PubMed ID: 8074651)
21. Probing electron transfer in flavocytochrome P-450 BM3 and its component domains.
Munro AW; Daff S; Coggins JR; Lindsay JG; Chapman SK
Eur J Biochem; 1996 Jul; 239(2):403-9. PubMed ID: 8706747
[TBL] [Abstract][Full Text] [Related]
22. Switching pyridine nucleotide specificity in P450 BM3: mechanistic analysis of the W1046H and W1046A enzymes.
Neeli R; Roitel O; Scrutton NS; Munro AW
J Biol Chem; 2005 May; 280(18):17634-44. PubMed ID: 15710617
[TBL] [Abstract][Full Text] [Related]
23. Reconstitution of the fatty acid hydroxylase activity of cytochrome P450BM-3 utilizing its functional domains.
Sevrioukova I; Truan G; Peterson JA
Arch Biochem Biophys; 1997 Apr; 340(2):231-8. PubMed ID: 9143326
[TBL] [Abstract][Full Text] [Related]
24. Characterization of recombinant Bacillus megaterium cytochrome P-450 BM-3 and its two functional domains.
Li HY; Darwish K; Poulos TL
J Biol Chem; 1991 Jun; 266(18):11909-14. PubMed ID: 1904873
[TBL] [Abstract][Full Text] [Related]
25. Cobaltocene-mediated catalytic monooxygenation using holo and heme domain cytochrome P450 BM3.
Udit AK; Arnold FH; Gray HB
J Inorg Biochem; 2004 Sep; 98(9):1547-50. PubMed ID: 15337607
[TBL] [Abstract][Full Text] [Related]
26. The flavoprotein component of the Escherichia coli sulfite reductase: expression, purification, and spectral and catalytic properties of a monomeric form containing both the flavin adenine dinucleotide and the flavin mononucleotide cofactors.
Zeghouf M; Fontecave M; Macherel D; Covès J
Biochemistry; 1998 Apr; 37(17):6114-23. PubMed ID: 9558350
[TBL] [Abstract][Full Text] [Related]
27. Role of Ser457 of NADPH-cytochrome P450 oxidoreductase in catalysis and control of FAD oxidation-reduction potential.
Shen AL; Kasper CB
Biochemistry; 1996 Jul; 35(29):9451-9. PubMed ID: 8755724
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the interactions of cytochrome b5 with flavocytochrome P450 BM3 and its domains.
Noble MA; Girvan HM; Smith SJ; Smith WE; Murataliev M; Guzov VM; Feyereisen R; Munro AW
Drug Metab Rev; 2007; 39(2-3):599-617. PubMed ID: 17786641
[TBL] [Abstract][Full Text] [Related]
29. Global effects of the energetics of coenzyme binding: NADPH controls the protein interaction properties of human cytochrome P450 reductase.
Grunau A; Paine MJ; Ladbury JE; Gutierrez A
Biochemistry; 2006 Feb; 45(5):1421-34. PubMed ID: 16445284
[TBL] [Abstract][Full Text] [Related]
30. Flavin-binding and protein structural integrity studies on NADPH-cytochrome P450 reductase are consistent with the presence of distinct domains.
Narayanasami R; Horowitz PM; Masters BS
Arch Biochem Biophys; 1995 Jan; 316(1):267-74. PubMed ID: 7840627
[TBL] [Abstract][Full Text] [Related]
31. Crystal structure of the flavin reductase component (HpaC) of 4-hydroxyphenylacetate 3-monooxygenase from Thermus thermophilus HB8: Structural basis for the flavin affinity.
Kim SH; Hisano T; Iwasaki W; Ebihara A; Miki K
Proteins; 2008 Feb; 70(3):718-30. PubMed ID: 17729270
[TBL] [Abstract][Full Text] [Related]
32. Protein engineering of the cytochrome P450 monooxygenase from Bacillus megaterium.
Urlacher VB; Schmid RD
Methods Enzymol; 2004; 388():208-24. PubMed ID: 15289074
[No Abstract] [Full Text] [Related]
33. Role of Asp1393 in catalysis, flavin reduction, NADP(H) binding, FAD thermodynamics, and regulation of the nNOS flavoprotein.
Konas DW; Takaya N; Sharma M; Stuehr DJ
Biochemistry; 2006 Oct; 45(41):12596-609. PubMed ID: 17029414
[TBL] [Abstract][Full Text] [Related]
34. Control of electron transfer in neuronal NO synthase.
Daff S; Noble MA; Craig DH; Rivers SL; Chapman SK; Munro AW; Fujiwara S; Rozhkova E; Sagami I; Shimizu T
Biochem Soc Trans; 2001 May; 29(Pt 2):147-52. PubMed ID: 11356143
[TBL] [Abstract][Full Text] [Related]
35. Atomic structure of ferredoxin-NADP+ reductase: prototype for a structurally novel flavoenzyme family.
Karplus PA; Daniels MJ; Herriott JR
Science; 1991 Jan; 251(4989):60-6. PubMed ID: 1986412
[TBL] [Abstract][Full Text] [Related]
36. Spectroscopic properties of Escherichia coli UDP-N-acetylenolpyruvylglucosamine reductase.
Axley MJ; Fairman R; Yanchunas J; Villafranca JJ; Robertson JG
Biochemistry; 1997 Jan; 36(4):812-22. PubMed ID: 9020779
[TBL] [Abstract][Full Text] [Related]
37. Role of the linker region connecting the reductase and heme domains in cytochrome P450BM-3.
Govindaraj S; Poulos TL
Biochemistry; 1995 Sep; 34(35):11221-6. PubMed ID: 7669780
[TBL] [Abstract][Full Text] [Related]
38. Preparation and characterization of a 5'-deazaFAD T491V NADPH-cytochrome P450 reductase.
Zhang H; Gruenke L; Saribas AS; Im SC; Shen AL; Kasper CB; Waskell L
Biochemistry; 2003 Jun; 42(22):6804-13. PubMed ID: 12779335
[TBL] [Abstract][Full Text] [Related]
39. Crystal structure of Escherichia coli thioredoxin reductase refined at 2 A resolution. Implications for a large conformational change during catalysis.
Waksman G; Krishna TS; Williams CH; Kuriyan J
J Mol Biol; 1994 Feb; 236(3):800-16. PubMed ID: 8114095
[TBL] [Abstract][Full Text] [Related]
40. Flavin supported fatty acid oxidation by the heme domain of Bacillus megaterium cytochrome P450BM-3.
Gonvindaraj S; Li H; Poulos TL
Biochem Biophys Res Commun; 1994 Sep; 203(3):1745-9. PubMed ID: 7945324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]